Treatment Outcomes in a Decentralized Antiretroviral Therapy Program: A Comparison of Two Levels of Care in North Central Nigeria

Table 3

Outcomes through 12 months of follow-up among patients initiating antiretroviral therapy in a decentralized HIV treatment program (2007–2011) in Jos, Nigeria.

Variable	Satellite sites	Prime site	𝑃 value
Time to HAART initiation (days)	84	32	<0.001
Time in care (months)	23 (6–98)	34 (6–98)	<0.001
Duration on HAART (months)	17 (0.4–59)	23 (0.3–59)	<0.001
Median CD4 increase (cells/mm^3)
12 weeks	53	128	<0.001
24 weeks	68	125	<0.001
48 weeks	91	123	0.03
Change in body weight (kg), mean (SD)
Baseline	57.1 (11.4)	58.6 (11.9)	<0.001
12 weeks	57.0 (10.7)	59.1 (11.8)	<0.001
24 weeks	57.1 (10.9)	58.5 (11.6)	0.003
48 weeks	57.5 (11.7)	58.2 (11.5)	0.11
Change in haemoglobin (g/dL)
12 weeks	11	11	0.001
24 weeks	11.5	11	0.68
48 weeks	11.8	12	0.39
Transfers (%)	205 (5.5)	349 (8.7)	<0.001
Deaths (%)	201 (5.0)	85 (2.3)	<0.001